$BMRA I took a huge cut by selling out. I know that there are EUA & CE mark in play. However, this management is short-sighted and blinded by short-term payout and has no interest in attracting new retail investors. They are completely dishonest and unethical. It is difficult to conclude that the management is just incompetent. The stock may temporarily Moon if and when it does get FDA approvals. But the management will find a way to screw things up. It is not worth it.
  • 4